We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-22.77%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.72B
AUM Growth
-$1.36B
Cap. Flow
-$888M
Cap. Flow %
-51.56%
Top 10 Hldgs %
32.97%
Holding
299
New
73
Increased
48
Reduced
40
Closed
96

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$37.8M
2
GH icon
Guardant Health
GH
+$19.9M
3
LUNG icon
Pulmonx
LUNG
+$15.2M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.5M
5
LYRA
LYRA THERAPEUTICS INC
LYRA
+$11.2M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18M
2
CCCC icon
C4 Therapeutics
CCCC
+$15.2M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.5M
4
ICUI icon
ICU Medical
ICUI
+$12.8M
5
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
+$11.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.95%
2 Industrials 0.3%
3 Consumer Staples 0.27%
4 Materials 0.11%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VREX icon
276
PUT
Varex Imaging
VREX
$778M
– –
-750,000
Closed -$16M
WAT icon
277
PUT
Waters Corp
WAT
$40.9B
– –
-54,000
Closed -$16.8M
WBA
278
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-160,000
Closed -$7.16M
WVE icon
279
Wave Life Sciences
WVE
$1.03B
– –
-40,886
Closed -$82K
XLB icon
280
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.61B
– –
-250,000
Closed -$9.49M
XRAY icon
281
PUT
Dentsply Sirona
XRAY
$2.27B
– –
-368,000
Closed -$18.1M
ZBH icon
282
CALL
Zimmer Biomet
ZBH
$18.7B
– –
-225,000
Closed -$28.8M
ZTS icon
283
PUT
Zoetis
ZTS
$30.4B
– –
-28,000
Closed -$5.28M
EFTRW
284
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
– –
-100,541
Closed -$35K
HLTH
285
PUT
DELISTED
Cue Health Inc. Common Stock
HLTH
– –
-114,500
Closed -$739K
KDNY
286
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-85,236
Closed -$1.39M
DALS
287
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
– –
-164,834
Closed -$1.6M
VRAY
288
CALL
DELISTED
ViewRay, Inc.
VRAY
– –
-2,500,000
Closed -$9.8M
GRNA
289
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
– –
-400,000
Closed -$3.85M
CSII
290
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-10,911
Closed -$247K
RUBY
291
CALL
DELISTED
Rubius Therapeutics, Inc
RUBY
– –
-300,000
Closed -$1.65M
QTNT
292
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-12,500
Closed -$600K
CNVY
293
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
– –
-1,720,752
Closed -$11.3M
TCACU
294
DELISTED
Tuatara Capital Acquisition Corporation Unit
TCACU
– –
-20,000
Closed -$198K
BHVN
295
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-10,985
Closed -$1.3M
8 9 10 11
12

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2022 Portfolio in Review

As of Q2 2022, Pura Vida Investments held 299 positions worth $1.72B, down 44% from $3.08B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Pura Vida Investments withdrew a net $888M in Q2 2022, closing 96 positions and reducing 40 holdings. Its most notable exit was C4 Therapeutics, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Pura Vida Investments opened a new position in Glaukos worth $36.2M.

  • Pura Vida Investments's largest Q2 2022 buy was Glaukos: 796,600 shares worth $36.2M.
  • Pura Vida Investments added most to Guardant Health in Q2 2022, an estimated $19.9M increase.
  • Pura Vida Investments's biggest Q2 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $18M.
  • Pura Vida Investments fully exited C4 Therapeutics in Q2 2022, selling an estimated $15.2M.
  • Pura Vida Investments's ten largest holdings make up 33% of its $1.72B portfolio in Q2 2022.
  • Pura Vida Investments opened 73 new positions and closed 96 in Q2 2022.
  • Pura Vida Investments's portfolio value fell 44% quarter-over-quarter to $1.72B.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.